Cargando…
PPARα activator irbesartan suppresses the proliferation of endometrial carcinoma cells via SREBP1 and ARID1A
Endometrial carcinoma (EMC) is associated with obesity; however, the underlying mechanisms have not yet been elucidated. Peroxisome proliferator-activated receptor alpha (PPARα) is a nuclear receptor that is involved in lipid, glucose, and energy metabolism. PPARα reportedly functions as a tumor sup...
Autores principales: | LU, YU, MIYAMOTO, TSUTOMU, TAKEUCHI, HODAKA, TSUNODA, FUMI, TANAKA, NAOKI, SHIOZAWA, TANRI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tech Science Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229307/ https://www.ncbi.nlm.nih.gov/pubmed/37305395 http://dx.doi.org/10.32604/or.2023.026067 |
Ejemplares similares
-
Anti-tumor effect of Wasabi component, 6-(methylsulfinyl) hexyl isothiocyanate, against endometrial carcinoma cells
por: Ono, Motoki, et al.
Publicado: (2023) -
αGlcNAc and its catalyst α4GnT are diagnostic and prognostic markers in uterine cervical tumor, gastric type
por: Ida, Koichi, et al.
Publicado: (2019) -
Establishment of a novel model of endometriosis-associated ovarian cancer by transplanting uterine tissue from Arid1a/Pten knockout mice
por: Ono, Motoki, et al.
Publicado: (2023) -
Biology and management of lobular endocervical glandular hyperplasia
por: Miyamoto, Tsutomu, et al.
Publicado: (2022) -
Cyclin A2 confers cisplatin resistance to endometrial carcinoma cells via up-regulation of an Akt-binding protein, periplakin
por: Suzuki, Akihisa, et al.
Publicado: (2010)